200 related articles for article (PubMed ID: 27092665)
1. Metabolic assessment of Merkel cell carcinoma: the role of 18F-FDG PET/CT.
Ben-Haim S; Garkaby J; Primashvili N; Goshen E; Shapira R; Davidson T; Israel O; Epelbaum R
Nucl Med Commun; 2016 Aug; 37(8):865-73. PubMed ID: 27092665
[TBL] [Abstract][Full Text] [Related]
2. Lack of clinical impact of
Liu J; Larcos G; Howle J; Veness M
Australas J Dermatol; 2017 May; 58(2):99-105. PubMed ID: 26459330
[TBL] [Abstract][Full Text] [Related]
3. 15-Year Experience of 18F-FDG PET Imaging in Response Assessment and Restaging After Definitive Treatment of Merkel Cell Carcinoma.
Byrne K; Siva S; Chait L; Callahan J; Bressel M; Seel M; MacManus MP; Hicks RJ
J Nucl Med; 2015 Sep; 56(9):1328-33. PubMed ID: 26159592
[TBL] [Abstract][Full Text] [Related]
4. The impact of (18)F-FDG-PET/CT on Merkel cell carcinoma management: a retrospective study of 66 scans from a single institution.
George A; Girault S; Testard A; Delva R; Soulié P; Couturier OF; Morel O
Nucl Med Commun; 2014 Mar; 35(3):282-90. PubMed ID: 24240193
[TBL] [Abstract][Full Text] [Related]
5. 18F-fluorodeoxyglucose positron emission tomography-computed tomography imaging in the management of Merkel cell carcinoma: a single-institution retrospective study.
Ibrahim SF; Ahronowitz I; McCalmont TH; Hernandez Pampaloni M; Ryan JL; Yu SS
Dermatol Surg; 2013 Sep; 39(9):1323-33. PubMed ID: 23777452
[TBL] [Abstract][Full Text] [Related]
6. 18F-FDG PET provides high-impact and powerful prognostic stratification in the staging of Merkel cell carcinoma: a 15-year institutional experience.
Siva S; Byrne K; Seel M; Bressel M; Jacobs D; Callahan J; Laing J; Macmanus MP; Hicks RJ
J Nucl Med; 2013 Aug; 54(8):1223-9. PubMed ID: 23753187
[TBL] [Abstract][Full Text] [Related]
7. Positron emission tomography/computed tomography imaging in Merkel cell carcinoma: a study of 270 scans in 97 patients at the Dana-Farber/Brigham and Women's Cancer Center.
Hawryluk EB; O'Regan KN; Sheehy N; Guo Y; Dorosario A; Sakellis CG; Jacene HA; Wang LC
J Am Acad Dermatol; 2013 Apr; 68(4):592-599. PubMed ID: 23127473
[TBL] [Abstract][Full Text] [Related]
8. The impact of (18)F-FDG PET-CT scanning for staging and management of Merkel cell carcinoma: results from Westmead Hospital, Sydney, Australia.
Concannon R; Larcos GS; Veness M
J Am Acad Dermatol; 2010 Jan; 62(1):76-84. PubMed ID: 20082888
[TBL] [Abstract][Full Text] [Related]
9. Merkel cell carcinoma: Is there a role for 2-deoxy-2-[f-18]fluoro-D-glucose-positron emission tomography/computed tomography?
Iagaru A; Quon A; McDougall IR; Gambhir SS
Mol Imaging Biol; 2006; 8(4):212-7. PubMed ID: 16724293
[TBL] [Abstract][Full Text] [Related]
10. Somatostatin receptor positron emission tomography/computed tomography imaging in Merkel cell carcinoma.
Sollini M; Taralli S; Milella M; Erba PA; Rubagotti S; Fraternali A; Roncali M; Moscarella E; Perotti G; Rufini V; Versari A
J Eur Acad Dermatol Venereol; 2016 Sep; 30(9):1507-11. PubMed ID: 26446694
[TBL] [Abstract][Full Text] [Related]
11. Clinical utility of F-18 FDG PET/CT in recurrent breast carcinoma.
Manohar K; Mittal BR; Senthil R; Kashyap R; Bhattacharya A; Singh G
Nucl Med Commun; 2012 Jun; 33(6):591-6. PubMed ID: 22334135
[TBL] [Abstract][Full Text] [Related]
12. Prospective analysis of the utility of 18-FDG PET in Merkel cell carcinoma of the skin: A Trans Tasman Radiation Oncology Group Study, TROG 09:03.
Poulsen M; Macfarlane D; Veness M; Estall V; Hruby G; Kumar M; Pullar A; Tripcony L; Rischin D
J Med Imaging Radiat Oncol; 2018 Jun; 62(3):412-419. PubMed ID: 29405630
[TBL] [Abstract][Full Text] [Related]
13. Clinical Impact of FDG PET/CT of the Lower Extremities in Patients With Merkel Cell Carcinoma With Primary Disease Site Outside of the Lower Extremities.
Ishiyama M; Behnia F; Vesselle H
AJR Am J Roentgenol; 2021 Mar; 216(3):776-780. PubMed ID: 33474987
[No Abstract] [Full Text] [Related]
14. Diagnostic performance of fluorine-18-fluorodeoxyglucose positron emission tomography in patients with Merkel cell carcinoma: a systematic review and meta-analysis.
Treglia G; Kakhki VR; Giovanella L; Sadeghi R
Am J Clin Dermatol; 2013 Dec; 14(6):437-47. PubMed ID: 23959776
[TBL] [Abstract][Full Text] [Related]
15.
Mahajan S; Barker CA; Mauguen A; D'Angelo SP; Yeh R; Pandit-Taskar N
J Nucl Med; 2022 Jun; 63(6):906-911. PubMed ID: 34620729
[TBL] [Abstract][Full Text] [Related]
16. The role of 18F-FDG PET/CT in staging and restaging primary bone lymphoma.
Liu Y
Nucl Med Commun; 2017 Apr; 38(4):319-324. PubMed ID: 28225435
[TBL] [Abstract][Full Text] [Related]
17. Merkel cell carcinoma: two case reports focusing on the role of fluorodeoxyglucose positron emission tomography imaging in staging and surveillance.
Yao M; Smith RB; Hoffman HT; Funk GF; Graham MM; Buatti JM
Am J Clin Oncol; 2005 Apr; 28(2):205-10. PubMed ID: 15803018
[TBL] [Abstract][Full Text] [Related]
18. Risk factors and stratification for recurrence of patients with differentiated thyroid cancer, elevated thyroglobulin and negative I-131 whole-body scan, by restaging
Okuyucu K; Ince S; Alagoz E; Emer O; San H; Balkan E; Ayan A; Meric C; Haymana C; Acıkel C; Gunalp B; Karacalioglu AO; Arslan N
Hell J Nucl Med; 2016; 19(3):208-217. PubMed ID: 27824959
[TBL] [Abstract][Full Text] [Related]
19. Comparison of 18F-FDG PET/CT and 111In pentetreotide scan for detection of Merkel cell carcinoma.
Lu Y; Fleming SE; Fields RC; Coit DG; Carrasquillo JA
Clin Nucl Med; 2012 Aug; 37(8):759-62. PubMed ID: 22785503
[TBL] [Abstract][Full Text] [Related]
20. PET/CT-guided percutaneous biopsy of FDG-avid metastatic bone lesions in patients with advanced lung cancer: a safe and effective technique.
Guo W; Hao B; Chen HJ; Zhao L; Luo ZM; Wu H; Sun L
Eur J Nucl Med Mol Imaging; 2017 Jan; 44(1):25-32. PubMed ID: 27444682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]